Breed Overview
The Vizsla (Hungarian Pointer) is a versatile gundog belonging to FCI Group 7 — Continental Pointing Dogs. Bred for centuries in Hungary as a multi-purpose hunting dog capable of pointing, flushing, and retrieving, the Vizsla is a medium-sized, lean, athletic dog with a distinctive golden-rust coat and an exceptionally affectionate temperament. It is recognised by the Kennel Club in the UK and has grown considerably in popularity across Europe over the past two decades, valued as both a working dog and a loyal family companion.
One of the Vizsla's notable characteristics is its relatively long lifespan — 12 to 15 years is typical, which places it among the longer-lived of the larger breeds. However, this lifespan advantage comes with a caveat: the breed has some specific health vulnerabilities, including a higher-than-average incidence of certain cancers, idiopathic epilepsy, and immune-mediated conditions. Understanding these risks, undertaking appropriate health screening, and choosing a puppy from tested parents are the most important steps an owner can take.
Hip Dysplasia
Hip dysplasia remains one of the most important orthopaedic conditions in the Vizsla, as it does in many medium and large breeds. The condition involves abnormal development of the hip joint, leading to joint laxity, progressive cartilage damage, and osteoarthritis. Affected dogs may show a reluctance to exercise, stiffness after rest, difficulty jumping, and a characteristic swaying gait. Severity varies considerably — some dogs with radiographic changes remain relatively comfortable, while others are significantly impaired.
In the UK, the BVA/KC hip scoring scheme is the standard assessment tool. Hip X-rays are taken and scored by BVA-appointed scrutineers; the score for each hip is added together to give a total score, with lower numbers indicating better hip conformation. Breeders should screen all dogs intended for breeding and use only those with scores below the breed median. In mainland Europe, the FCI hip grading scheme (grades A through E) is used, and most European Vizsla breed clubs require grade A or B for breeding. Ask to see hip scores for both parents when purchasing a puppy.
Idiopathic Epilepsy
Idiopathic (or familial) epilepsy — epilepsy with no identifiable underlying cause other than a presumed genetic predisposition — affects the Vizsla at a higher rate than many other breeds. Estimates suggest that around two per cent of Vizslas are affected, though the true figure may be higher given that mild or infrequent seizures can go undiagnosed. The condition typically becomes apparent between one and five years of age.
Seizures in dogs can take many forms, from brief absence events or focal twitching to full generalised convulsions with loss of consciousness, paddling, and vocalisation. A dog that has experienced a seizure should be seen by a veterinarian as soon as possible, both to investigate the cause and to assess whether treatment is required. Idiopathic epilepsy is diagnosed by excluding other possible causes through blood tests, urine analysis, and, in some cases, MRI scanning and cerebrospinal fluid analysis.
Treatment with anti-epileptic medication (such as phenobarbitone, potassium bromide, or imepitoin) is typically initiated when seizures are frequent, prolonged, or occurring in clusters. With appropriate management, many epileptic Vizslas live normal lifespans with good quality of life. Unlike some other conditions, there is currently no widely available commercial DNA test for idiopathic epilepsy in the Vizsla, meaning that breeding decisions must be based on the known health histories of close relatives. Responsible breeders discuss epilepsy openly and avoid using affected dogs or dogs from heavily affected lines for breeding.
Lymphoma
The Vizsla has a higher incidence of lymphoma (cancer of the lymphatic system) than the general dog population, and this is one of the breed's most significant health concerns. Lymphoma is one of the most common cancers in dogs overall, but Vizslas appear to be predisposed at a rate above the breed average. The condition can affect lymph nodes throughout the body and may also involve internal organs including the liver and spleen.
Signs of lymphoma can include swollen lymph nodes (felt as firm lumps under the jaw, in front of the shoulders, behind the knees, or in the groin), weight loss, reduced appetite, lethargy, increased thirst and urination, and in some cases digestive disturbance. Diagnosis is confirmed through sampling of affected lymph nodes (fine needle aspirate or biopsy) and staging investigations including blood tests, chest X-rays, and abdominal ultrasound. Treatment with combination chemotherapy can achieve remission in a significant proportion of cases, with many dogs enjoying a good quality of life for a year or more after diagnosis. Owners should regularly check their dog's lymph nodes as part of routine health monitoring and report any swelling to their vet promptly.
Mast Cell Tumours
Mast cell tumours (MCTs) are another type of cancer seen with increased frequency in Vizslas. Mast cells are a normal component of the immune system, but when they become cancerous they can form tumours in the skin or internal organs. Skin mast cell tumours in dogs often appear as raised, variable lumps that may fluctuate in size — sometimes appearing to reduce before growing again — and can be accompanied by localised redness and swelling. Any new lump discovered on a Vizsla should be assessed by a veterinarian without delay; fine needle aspiration (a simple, minimally invasive sampling technique) can often provide a rapid diagnosis. Grade determines prognosis and guides treatment, which may include surgical removal, radiation therapy, or targeted medical treatment.
Hypothyroidism
Hypothyroidism — reduced production of thyroid hormones due to underactivity or disease of the thyroid gland — is seen in Vizslas as it is in many other breeds. Signs include unexplained weight gain without a change in diet, lethargy, exercise intolerance, recurring skin infections, a dull or thinning coat, and intolerance of cold. Blood testing to assess thyroid hormone levels (ideally a full thyroid panel including free T4 and thyroid-stimulating hormone) is recommended for dogs showing these signs and for breeding dogs. Hypothyroidism is managed effectively with daily oral supplementation of synthetic thyroid hormone and should not significantly affect life expectancy when treated consistently.
Progressive Retinal Atrophy
Progressive retinal atrophy (PRA) is a hereditary condition causing degeneration of the retinal photoreceptor cells, ultimately resulting in blindness. Affected dogs first lose their ability to see in low light conditions (night blindness), followed by progressive loss of day vision over months to years. PRA is inherited, and DNA testing allows breeders to identify clear, carrier, and affected dogs before breeding decisions are made, preventing the production of affected puppies.
DNA tests for PRA in the Vizsla are available from laboratories including Laboklin and Optigen. All breeding Vizslas should be tested, and annual eye examinations through the BVA/KC/ISDS scheme are recommended for early detection of clinical signs. A dog that is confirmed clear by DNA test does not need repeated eye examinations for PRA, though other eye conditions can still develop.
Polymyositis and Immune-Mediated Muscle Disease
The Vizsla appears to have a predisposition to polymyositis — an immune-mediated inflammatory condition affecting the muscles. Affected dogs may show generalised weakness, muscle wasting (particularly of the muscles of the head, giving a sunken, hollow appearance), difficulty swallowing (dysphagia), weight loss, and exercise intolerance. Diagnosis involves blood tests including creatine kinase levels, electromyography, and muscle biopsy. Treatment typically involves immunosuppressive medication. The condition can be challenging to manage long-term, and the prognosis varies between individual dogs.
The Wirehaired Vizsla
It is worth noting that the Wirehaired Vizsla is recognised by the FCI as a separate breed (also in Group 7) from the smooth-coated Hungarian Vizsla, and has its own distinct breed standard and gene pool. While the two breeds share historical origins and a broadly similar health profile, they are not interchangeable, and health data from one should not automatically be applied to the other. Owners of Wirehaired Vizslas should consult their specific breed club for health screening recommendations relevant to their dog.
Exercise, Stimulation and General Care
The Vizsla is a highly energetic breed with strong working instincts. Insufficient exercise and mental stimulation frequently lead to destructive behaviour, anxiety, and frustration in this breed. The Vizsla also bonds very deeply with its human family and does not thrive when left alone for extended periods — separation anxiety is common in dogs of this breed that do not receive adequate companionship and routine.
- Plan for a minimum of two hours of vigorous daily exercise for an adult Vizsla
- Include activities that engage the dog's scenting instincts, such as tracking, nose work, or hunt-point-retrieve training
- Be cautious with harsh shampoos and grooming products — the Vizsla has sensitive skin that can react to strong chemicals
- Monitor bodyweight, as the lean build of a healthy Vizsla can mask gradual weight change; a visible waist and palpable ribs are normal and desirable
- Regular veterinary check-ups including lymph node palpation are recommended given the breed's cancer risk
Recommended Health Screening Summary
- BVA/KC hip scoring (UK) or FCI hip grading (Europe) — for all breeding dogs
- PRA DNA test (Laboklin or Optigen) — for all breeding dogs
- BVA/KC/ISDS annual eye examination — for all breeding dogs not DNA-cleared
- Full thyroid panel — for breeding dogs and any dog showing signs of hypothyroidism
- Awareness of epilepsy family history — ask breeders about epilepsy in close relatives
- Regular owner lymph node checks and prompt veterinary assessment of any new lumps
The Vizsla community in the UK is well organised through the Hungarian Vizsla Club, which maintains health data and provides guidance on recommended testing. Consulting the breed club and purchasing from breeders who are actively involved in health monitoring gives the best chance of acquiring a healthy, long-lived dog.